R. Rabinovitch

发表

Variability of target and normal structure delineation for breast cancer radiotherapy: an RTOG Multi-Institutional and Multiobserver Study.

W. Woodward, T. Buchholz, X. Li, 2007, International journal of radiation oncology, biology, physics.

ACR Appropriateness Criteria® on nonpalpable mammographic findings (excluding calcifications).

C. D'Orsi, R. Birdwell, L. Bassett, 2010, Journal of the American College of Radiology : JACR.

Randomized phase III trial to evaluate radiopharmaceuticals and zoledronic acid in the palliation of osteoblastic metastases from lung, breast, and prostate cancer: report of the NRG Oncology RTOG 0517 trial

L. Kachnic, C. Langer, L. Berk, 2018, Annals of Nuclear Medicine.

Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial.

Adam P Dicker, Charles R. Thomas, I-Chow Hsu, 2018, The Lancet. Oncology.

A Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95-17.

R. M. Wilenzick, W. Hanson, D. Arthur, 2008, International journal of radiation oncology, biology, physics.

ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast.

S. Edge, M. Cobleigh, B. Haffty, 2009, International journal of radiation oncology, biology, physics.

Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/ II breast carcinoma.

F. Vicini, J. Wong, D. Arthur, 2008, International journal of radiation oncology, biology, physics.

Radiographic evaluation of surgical clips is better than ultrasound for defining the lumpectomy cavity in breast boost treatment planning: a prospective clinical study.

J. Lewin, W. Biffl, R. Franciose, 2000, International journal of radiation oncology, biology, physics.

The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.

A. Amini, N. Yeh, B. Jones, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Non-Hodgkin's lymphomas, version 4.2014.

J. Byrd, R. Advani, J. Vose, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

OT2-06-02: A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) vs Partial Breast Irradiation (PBI) for Women with Stage 0, 1, or 2 Breast Cancer: NSABP B-39/RTOG 0413.

W. Curran, T. Julian, F. Vicini, 2011 .

A Phase II Trial of Brachytherapy Alone Following Lumpectomy for Select Breast Cancer : tumor control and survival outcomes of RTOG 95-17

W. Hanson, D. Arthur, J. White, 2008 .

Early-stage BRCA2-linked breast cancer diagnosed in the first trimester of pregnancy associated with a hypercoagulable state.

P. Kabos, J. Diamond, V. Borges, 2009, Oncology.

Patterns of Fractionation and Boost Usage in Adjuvant External Beam Radiotherapy for Ductal Carcinoma in Situ in the United States

A. Amini, P. Kabos, R. Rabinovitch, 2017, Clinical breast cancer.

Inferior outcomes and treatment disparities in elderly patients with classical Hodgkin lymphoma: a national cancer data base analysis

Derek E. Smith, R. Rabinovitch, M. Kamdar, 2018, Leukemia & lymphoma.

Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

R. Advani, P. Bierman, L. Gordon, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY Hodgkin Lymphoma, Version 2.2020

R. Advani, P. Bierman, L. Gordon, 2020 .

Patient-reported outcomes (PROs) in NRG oncology/NSABP B-39/RTOG 0413: A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) in stage 0, I, or II breast cancer.

W. Curran, M. Scheier, H. Kuerer, 2019, Journal of Clinical Oncology.

Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials

R. Socher, James Y. Zou, S. Yeung, 2022, npj Digital Medicine.

Hodgkin lymphoma, version 2.2015.

R. Advani, P. Bierman, L. Gordon, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Radiation Associated Secondary Malignancies in BRCA Mutation Carriers Treated for Breast Cancer.

E. Friedman, M. Ben-David, R. Rabinovitch, 2020, International journal of radiation oncology, biology, physics.

Comparison of Radiation With or Without Concurrent Trastuzumab for HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy: A Phase III Clinical Trial

T. Julian, N. Wolmark, K. Siziopikou, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast conservation therapy in affiliated county, university, and private hospitals.

J. Heimbach, W. Biffl, E. Mitchell, 1999, American journal of surgery.

Superiority of radio-opaque clips compared to ultrasound as methods of defining lumpectomy cavity volumes for breast boost planning

L. Norton, R. Franciose, R. Rabinovitch, 1998 .

Left-sided breast cancer irradiation using rotational and fixed-field radiotherapy.

B. Kavanagh, R. Rabinovitch, Arthur K Liu, 2014, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Respiratory organ motion and dosimetric impact on breast and nodal irradiation.

X. Li, M. Miften, K. Merrell, 2010, International journal of radiation oncology, biology, physics.

Preliminary results of centralized HER2 testing in ductal carcinoma in situ (DCIS): NSABP B-43

W. McCaskill-Stevens, T. Julian, J. Costantino, 2013, Breast Cancer Research and Treatment.

Local regional recurrence and salvage surgery. American College of Radiology. ACR Appropriateness Criteria.

S. Singletary, S. Mitchell, L. Solin, 2000, Radiology.

A young woman with a small ER-positive breast cancer, a micrometastatic axillary lymph node, and an intermediate oncotype DX recurrence score.

Meenakshi Singh, V. Borges, A. Elias, 2007, Oncology.

Abstract S3-06: A phase III trial evaluating pCR in patients with HR+, HER2-positive breast cancer treated with neoadjuvant docetaxel, carboplatin, trastuzumab, and pertuzumab (TCHP) +/- estrogen deprivation: NRG Oncology/NSABP B-52

S. Paik, N. Wolmark, S. Swain, 2017 .

Conservative surgery and radiation in the treatment of stage I and II carcinoma of the breast. American College of Radiology. ACR Appropriateness Criteria.

S. Singletary, S. Mitchell, L. Solin, 2000, Radiology.

Ductal carcinoma in situ and microinvasive disease. American College of Radiology. ACR Appropriateness Criteria.

S. Singletary, S. Mitchell, L. Solin, 2000, Radiology.

Non-Hodgkin's lymphomas, version 2.2014.

J. Byrd, R. Advani, J. Vose, 2014, Journal of the National Comprehensive Cancer Network : JNCCN.

Long term update of NRG Oncology RTOG 0319: A Phase I/II Trial to Evaluate Three Dimensional Conformal Radiation Therapy (3D-CRT) Confined to the Region of the Lumpectomy Cavity for Stage I and II Breast Carcinoma

F. Vicini, D. Arthur, R. Rabinovitch, 2017 .

American Brachytherapy Society Task Group Report: Long-term control and toxicity with brachytherapy for localized breast cancer.

B. Amendola, L. Kim, S. Beriwal, 2017, Brachytherapy.

A phase II trial of brachytherapy alone following lumpectomy for stage I or II breast cancer: initial outcomes of RTOG 9517

R. M. Wilenzick, W. Hanson, D. Arthur, 2004 .

Postmastectomy radiotherapy. American College of Radiology. ACR Appropriateness Criteria.

S. Singletary, A. Recht, S. Mitchell, 2000, Radiology.

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.

J. Byrd, R. Advani, J. Vose, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Non-Hodgkin’s Lymphomas, Version 4.2014: Clinical Practice Guidelines in Oncology

J. Byrd, R. Advani, J. Vose, 2014 .

Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015.

J. Byrd, R. Advani, J. Vose, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

Presymptomatic Awareness of Germline Pathogenic BRCA Variants and Associated Outcomes in Women With Breast Cancer.

E. Levy-Lahad, S. Lieberman, R. Rabinovitch, 2020, JAMA oncology.

Phase II trial of brachytherapy alone after lumpectomy for select breast cancer: toxicity analysis of RTOG 95-17.

R. M. Wilenzick, W. Hanson, D. Arthur, 2006, International journal of radiation oncology, biology, physics.

Bacterial infections in a hospital-based skilled nursing facility.

R. Rabinovitch, E. Duthie, S. Gambert, 1982, Journal of chronic diseases.

Dose specification and quality assurance of RTOG protocol 95-17; a cooperative group study of 192 Ir breast implants as sole therapy

G. Ibbott, W. Hanson, D. Arthur, 2001 .

NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019.

R. Advani, J. Vose, L. Gordon, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Venetoclax and azacitidine followed by allogeneic transplant results in excellent outcomes and may improve outcomes versus maintenance therapy among newly diagnosed AML patients older than 60

C. McMahon, Amanda C. Winters, D. Pollyea, 2021, Bone Marrow Transplantation.

Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.

R. Advani, P. Bierman, L. Gordon, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Accelerated partial-breast irradiation: trial by media or by science?

T. Julian, F. Vicini, M. Anscher, 2012, International journal of radiation oncology, biology, physics.

Intensive chemotherapy for progressive chronic lymphocytic leukemia administered early after a nonmyeloablative allograft

Y. Nieto, R. Rabinovitch, P. Cagnoni, 2001, Bone Marrow Transplantation.

RTOG 95-17, a Phase II trial to evaluate brachytherapy as the sole method of radiation therapy for Stage I and II breast carcinoma--year-5 toxicity and cosmesis.

F. Vicini, D. Arthur, J. White, 2014, Brachytherapy.

Initial efficacy results of RTOG 0319: three-dimensional conformal radiation therapy (3D-CRT) confined to the region of the lumpectomy cavity for stage I/ II breast carcinoma.

F. Vicini, J. Wong, D. Arthur, 2008, International journal of radiation oncology, biology, physics.

A phase I/II trial of brachytherapy alone following lumpectomy for select breast cancer: toxicity analysis of radiation therapy oncology group 95-17

R. M. Wilenzick, W. Hanson, D. Arthur, 2002 .

American College of Radiology appropriateness criteria on conservative surgery and radiation: stages I and II breast carcinoma.

S. Edge, L. Solin, B. Haffty, 2008, Journal of the American College of Radiology : JACR.

Improved cosmesis in early breast cancer using conformal radiotherapy.

B. Kavanagh, N. Mohideen, R. Rabinovitch, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-Term Cancer Outcomes From Study NRG Oncology/RTOG 9517: A Phase 2 Study of Accelerated Partial Breast Irradiation With Multicatheter Brachytherapy After Lumpectomy for Early-Stage Breast Cancer.

F. Vicini, D. Arthur, J. White, 2016, International journal of radiation oncology, biology, physics.

Abstract GS4-04: Primary results of NSABP B-39/RTOG 0413 (NRG Oncology): A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer

W. Curran, M. Scheier, G. Gustafson, 2019, General Session Abstracts.

Early toxicity results with 3D conformal external beam therapy (CEBT) from the NSABP B-39/RTOG 0413 accelerated partial breast irradiation (APBI) trial.

W. Curran, T. Julian, F. Vicini, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Novel Biosignature Identifies Patients With DCIS With High Risk of Local Recurrence After Breast Conserving Surgery and Radiation Therapy.

F. Vicini, G. Mann, D. Dabbs, 2022, International journal of radiation oncology, biology, physics.

Response to "Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation" (Int J Radiat Oncol Biol Phys 2010;76:71-78) and "Toxicity of three-dimensional conformal radiotherapy for accelerated partial bre

W. Curran, T. Julian, F. Vicini, 2010, International journal of radiation oncology, biology, physics.

Improved Cosmesis in Early Breast Cancer Using

B. Kavanagh, N. Mohideen, R. Rabinovitch, 2013 .

Late toxicity and patient self-assessment of breast appearance/satisfaction on RTOG 0319: a phase 2 trial of 3-dimensional conformal radiation therapy-accelerated partial breast irradiation following lumpectomy for stages I and II breast cancer.

F. Vicini, J. Wong, D. Arthur, 2013, International journal of radiation oncology, biology, physics.

SU‐E‐T‐800: Evaluation of Left‐Sided Breast Cancer Treatment Using Rotational and Fixed‐Gantry Radiotherapy

B. Kavanagh, R. Rabinovitch, Arthur K Liu, 2011 .

Regression of a Fungating Tumor After Hypofractionated Radiation Therapy in a Patient With Metastatic Breast Cancer

A. Amini, R. Rabinovitch, K. Quackenbush, 2017, Cureus.

American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Total Body Irradiation (TBI)

J. Galvin, S. Rosenthal, S. Wolden, 2013, American journal of clinical oncology.

NCCN guidelines® insights chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia, Version 1.2017: Featured updates to the NCCN guidelines

J. Byrd, R. Advani, J. Vose, 2017 .

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017.

J. Byrd, R. Advani, J. Vose, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials.

W. Curran, J. Galvin, C. Willett, 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Long-Term Control of Primary Cerebral ALH Amyloidoma With Focal Radiation Therapy

D. Ney, R. Rabinovitch, Andrew B. Wolf, 2021, Advances in Radiation Oncology.

Tacrolimus and mycophenolate mofetil after nonmyeloablative matched-sibling donor allogeneic stem-cell transplantations conditioned with fludarabine and low-dose total body irradiation.

E. Shpall, A. Baron, Y. Nieto, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Radiation recall after COVID-19 infection

R. Rabinovitch, R. B. Ross, 2022, The Lancet Oncology.

Spontaneous regression of a postpartum pituitary mass demonstrated by computed tomography.

D. Daniels, R. Rabinovitch, J. Cerletty, 1982, Archives of internal medicine.

CONSERVATIVE SURGERY AND RADIATION—STAGE I AND II BREAST CANCER

Catherine C. Park, E. Harris, D. Toppmeyer, 2015 .

Patterns of failure following surgical resection of renal cell carcinoma: implications for adjuvant local and systemic therapy.

M. Zelefsky, Z. Fuks, J. Gaynor, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of a biopsy-based genomic classifier in high-risk prostate cancer: Meta-analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 phase III randomized trials.

H. Sandler, F. Feng, D. Spratt, 2022, International journal of radiation oncology, biology, physics.

Chlamydia trachomatis in the pharynx and rectum of heterosexual patients at risk for genital infection.

B. Katz, R. Rabinovitch, T. Quinn, 1985, Annals of internal medicine.

PD-1 Blockade in Mediastinal Gray-Zone Lymphoma.

W. Wilson, E. Jaffe, S. Pittaluga, 2017, The New England journal of medicine.

NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018

R. Advani, P. Bierman, L. Gordon, 2018 .

Frontiers in radiotherapy for early-stage invasive breast cancer.

R. Rabinovitch, C. Fisher, C. Fisher, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases

Zenggang Pan, R. Baiocchi, P. Porcu, 2016, Current Hematologic Malignancy Reports.

Improved Survival With Radiation Therapy in Stage I-II Primary Mediastinal B Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis.

B. Jones, R. Rabinovitch, C. Rusthoven, 2014, International journal of radiation oncology, biology, physics.

Impact of nutrition support on treatment outcome in patients with locally advanced head and neck squamous cell cancer treated with definitive radiotherapy: A secondary analysis of RTOG trial 90‐03

J. Cooper, K. Fu, D. Raben, 2006, Head & neck.

Locally Advanced Breast Cancer

Catherine C. Park, E. Harris, D. Toppmeyer, 2019, Breast Diseases.

A 40-Year-Old Woman With a New Triple-Negative Breast Mass, Shown on Biopsy to Be Metaplastic Carcinoma.

V. Borges, C. Murphy, R. Rabinovitch, 2016, Oncology.

Improved survival in patients with early stage low‐grade follicular lymphoma treated with radiation

T. Pugh, R. Rabinovitch, F. Newman, 2010, Cancer.

Cardiac mortality in patients with stage I and II diffuse large B-cell lymphoma treated with and without radiation: a surveillance, epidemiology, and end-results analysis.

B. Kavanagh, T. Pugh, Kyle E. Rusthoven, 2010, International journal of radiation oncology, biology, physics.

Outcomes and effect of radiotherapy in patients with stage I or II diffuse large B-cell lymphoma: a surveillance, epidemiology, and end results analysis.

B. Kavanagh, Kyle E. Rusthoven, A. Schwer, 2008, International journal of radiation oncology, biology, physics.

Impact of postmastectomy radiotherapy in T3N0 invasive carcinoma of the breast

A. Schwer, R. Rabinovitch, C. Finlayson, 2008, Cancer.

Thiotepa-Based Intensified Reduced-Intensity Conditioning Adult Double-Unit Cord Blood Hematopoietic Stem Cell Transplantation Results in Decreased Relapse Rate and Improved Survival Compared with Transplantation Following Standard Reduced-Intensity Conditioning: A Retrospective Cohort Comparison.

E. Purev, D. Pollyea, R. Rabinovitch, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Adult cord blood transplant results in comparable overall survival and improved GRFS vs matched related transplant.

E. Purev, D. Pollyea, R. Rabinovitch, 2020, Blood advances.

The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?

A. Amini, P. Kabos, V. Borges, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Genomically Guided Breast Radiation Therapy: A Review of the Current Data and Future Directions

W. Woodward, J. Torres-Roca, E. Harris, 2021, Advances in radiation oncology.

Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis.

R. Rabinovitch, E. Fields, P. Dewitt, 2013, International journal of radiation oncology, biology, physics.

NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.

R. Advani, J. Vose, L. Gordon, 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

21-Gene Recurrence Score Assay As a Predictor of Adjuvant Chemotherapy Administration for Early-Stage Breast Cancer: An Analysis of Use, Therapeutic Implications, and Disparity Profile.

A. Amini, P. Kabos, V. Borges, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The integration of locoregional with systemic adjuvant therapy for early-stage breast cancer: the shifting sands of decision-making

J. Mayordomo, P. Kabos, J. Diamond, 2014 .

A detailed evaluation of TomoDirect 3DCRT planning for whole-breast radiation therapy.

M. Miften, D. Westerly, R. Rabinovitch, 2013, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial

W. Curran, M. Scheier, H. Kuerer, 2019, The Lancet.

Immunohistochemi-NCCN Diffuse Large B-Cell Lymphoma Version 1 . 2016 Clinical Practice Guidelines in Oncology

J. Byrd, R. Advani, J. Vose, 2016 .

Nonmyeloablative allogeneic hematopoietic stem cell transplantation for congenital sideroblastic anemia

E. Shpall, Y. Nieto, R. Rabinovitch, 2003, Bone Marrow Transplantation.

Combination of Trastuzumab Emtansine and Stereotactic Radiosurgery Results in High Rates of Clinically Significant Radionecrosis and Dysregulation of Aquaporin-4

L. Gaspar, B. Kavanagh, P. Kabos, 2019, Clinical Cancer Research.

43 – Cancer of the Kidney

Y. Yamada, S. Srinivas, T. Schefter, 2010 .

Phase I trial of bortezomib and concurrent external beam radiation in patients with advanced solid malignancies.

T. Pugh, D. Raben, Kyle E. Rusthoven, 2010, International journal of radiation oncology, biology, physics.

American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of high-dose-rate brachytherapy.

I. Hsu, B. Erickson, G. Ibbott, 2011, International journal of radiation oncology, biology, physics.

Double Helix of breast cancer therapy: intertwining the Halsted and Fisher hypotheses.

B. Kavanagh, R. Rabinovitch, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diffuse Large B-Cell Lymphoma Version 1.2016.

J. Byrd, R. Advani, J. Vose, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Advances in Treatment Techniques: Stereotactic Body Radiation Therapy and the Spread of Hypofractionation

Moyed Miften, B. Kavanagh, M. Miften, 2011, Cancer journal.

A woman with primary breast cancer and a solitary sternal metastasis.

Meenakshi Singh, V. Borges, A. Elias, 2006, Oncology.

22 – Partial Breast Irradiation

R. Rabinovitch, Rachel Rabinovitch, 2011 .

Improved survival with combined modality therapy in the modern era for primary mediastinal B‐cell lymphoma

B. Jones, R. Rabinovitch, C. Rusthoven, 2016, American journal of hematology.

Hodgkin Lymphoma Version 1 . 2017 Clinical Practice Guidelines in Oncology

R. Advani, P. Bierman, L. Gordon, 2017 .

A phase I/II trial to evaluate three-dimensional conformal radiation therapy confined to the region of the lumpectomy cavity for Stage I/II breast carcinoma: initial report of feasibility and reproducibility of Radiation Therapy Oncology Group (RTOG) Study 0319.

F. Vicini, J. Wong, W. Straube, 2005, International journal of radiation oncology, biology, physics.

Long-Term Update of NRG Oncology RTOG 0319: A Phase 1 and 2 Trial to Evaluate 3-Dimensional Conformal Radiation Therapy Confined to the Region of the Lumpectomy Cavity for Stage I and II Breast Carcinoma.

F. Vicini, J. Wong, D. Arthur, 2016, International journal of radiation oncology, biology, physics.

Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials

R. Socher, James Y. Zou, M. Lungren, 2022, npj Digital Medicine.

NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022.

R. Advani, L. Gordon, M. Kaminski, 2022, Journal of the National Comprehensive Cancer Network : JNCCN.

Risk and subtypes of secondary primary malignancies in diffuse large B‐cell lymphoma survivors change over time based on stage at diagnosis

Derek E. Smith, D. Ghosh, R. Rabinovitch, 2019, Cancer.

Hodgkin lymphoma-related vanishing bile duct syndrome and idiopathic cholestasis: Statistical analysis of all published cases and literature review

B. Kavanagh, H. Drabkin, R. Rabinovitch, 2008, Acta oncologica.

Cosmetic Outcome from Post Lumpectomy Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) on the NRG Oncology/NSABP B39-RTOG 0413 Phase III Clinical Trial

G. Gustafson, T. Julian, F. Vicini, 2019, International Journal of Radiation Oncology*Biology*Physics.

Dose specification and quality assurance of radiation therapy oncology group protocol 95-17; a cooperative group study of iridium-192 breast implants as sole therapy.

R. M. Wilenzick, G. Ibbott, W. Hanson, 2007, International journal of radiation oncology, biology, physics.

In Regard to Gillespie et al.

R. Rabinovitch, 2022, Practical radiation oncology.

Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202.

D. Grignon, H. Sandler, H. Lepor, 2015, International journal of radiation oncology, biology, physics.

Lessons Learned from Hurricane Maria in Puerto Rico: Practical Measures to Mitigate the Impact of a Catastrophic Natural Disaster on Radiation Oncology Patients

B. Erickson, R. Jagsi, B. Loo, 2019, International Journal of Radiation Oncology*Biology*Physics.

Title Duration of Androgen Deprivation in Locally Advanced Prostate Cancer : Long-Term

D. Grignon, H. Lepor, T. Pisansky, 2017 .

Evaluation of breast sentinel lymph node coverage by standard radiation therapy fields.

R. Rabinovitch, F. Newman, C. Finlayson, 2008, International journal of radiation oncology, biology, physics.

NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.

Chad A. LaGrange, Geoffrey E. Wile, R. Advani, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

A Phase I/II study of docetaxel, etoposide, and carboplatin before concurrent chemoradiotherapy with cisplatin and etoposide in limited-stage small cell lung cancer

P. Sunpaweravong, K. Kelly, P. Bunn, 2006, Investigational New Drugs.

Integration of automation into an existing clinical workflow to improve efficiency and reduce errors in the manual treatment planning process for total body irradiation (TBI)

Moyed Miften, Quentin Diot, Brian Kavanagh, 2020, Journal of applied clinical medical physics.

NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2017.

J. Byrd, R. Advani, J. Vose, 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

Assessing the benefit of adjuvant endocrine therapy in patients following breast-conserving surgery with or without radiation stratified by a 7-gene predictive DCIS biosignature.

F. Vicini, B. Czerniecki, D. Dabbs, 2022, Journal of Clinical Oncology.

Primary results of NRG Oncology / NSABP B-43: Phase III trial comparing concurrent trastuzumab (T) and radiation therapy (RT) with RT alone for women with HER2-positive ductal carcinoma in situ (DCIS) after lumpectomy.

T. Julian, N. Wolmark, K. Siziopikou, 2020 .

Abstract PD15-07: PD15-07 7-gene predictive biosignature improves risk stratification for breast ductal carcinoma in situ patients compared to clinicopathologic criteria, identifying a low risk group not clinically benefiting from adjuvant radiotherapy

F. Vicini, B. Czerniecki, G. Mann, 2023, Cancer Research.

Re-Thinking Clinicopathologic Risk Assessment in DCIS: Pooled Data from Validation Studies Comparing a 7-gene DCIS Assay to Clinicopathologic Features Alone

F. Vicini, G. Mann, D. Dabbs, 2022, International Journal of Radiation Oncology, Biology, Physics.

Relationships between alternative complement pathway activation, C-reactive protein, and pneumococcal infection

J. Kalbfleisch, R. Rabinovitch, L. Preheim, 1986, Journal of clinical microbiology.

NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.

R. Advani, P. Bierman, L. Gordon, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Improved survival in patients with early stage low‐grade follicular lymphoma treated with radiation

T. Pugh, R. Rabinovitch, F. Newman, 2010, Cancer.

American Society for Radiation Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of high-dose-rate brachytherapy.

B. Erickson, G. Ibbott, J. Tward, 2011, International journal of radiation oncology, biology, physics.